GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Inovalon Holdings INOV · USD

Health Care · US listing · 🇺🇸 United States

Compare

36.92

+1.71%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2020

Revenue

$667.5m

FY2014FY2020

Net income

$22.6m

FY2014FY2020

Free cash flow

$59.8m

FY2014FY2020

Shareholders' equity

$708.7m

FY2014FY2020

Income statement

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$667.5m$642.4m$527.7m$449.4m$427.6m$437.3m$361.5m
Gross profit$499.7m$474.6m$382.9m$298.3m$268.4m$291.1m$248.8m
Research and development$33.5m$33.7m$28.6m$27.4m$29.1m$22.3m$23.1m
Operating income$71.7m$69.5m$6.9m$33.8m$37.6m$116.5m$110.1m
Net income$22.6m$7.8m−$39.2m$34.8m$27.1m$66.1m$65.4m
Diluted earnings per share0.150.05-0.270.240.180.450.53

Balance sheet

At each fiscal year end

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$1.97bn$1.91bn$1.92bn$995.1m$1.05bn$1.11bn$342.6m
Cash and short-term investments$123.9m$93.1m$122.6m$476.2m$573.0m$728.2m$162.6m
Total liabilities$1.26bn$1.22bn$1.24bn$352.3m$369.8m$373.7m$350.8m
Debt$917.1m$908.5m$966.1m$248.7m$266.6m$281.7m$300.3m
Shareholders' equity$708.7m$688.2m$682.6m$642.8m$683.6m$739.2m−$8.2m
Shares outstanding150m149m145m143m151m148m122m

Cash flow

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations$146.4m$106.5m$90.4m$97.7m$92.8m$67.6m$85.5m
Capital spending−$86.6m−$58.9m−$65.0m−$65.5m−$39.0m−$26.4m−$22.7m
Free cash flow$59.8m$47.6m$25.4m$32.2m$53.8m$41.2m$62.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.1%8.8%—
Operating income28.5%-9.3%—
Net income-13.4%-19.3%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin74.4%72.4%70.3%—

Valuation history

At each fiscal year end

FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings73.6219.1-32.137.635.115.1
Price to sales2.52.72.42.92.22.3

Share price return

Finished calendar years

202520242023202120202019201820172016
Return19%7%7%125%-1%36%-9%60%-14%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.